Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings
- PMID: 20686384
- DOI: 10.1111/IGC.0b013e3181c50c7e
Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings
Abstract
Objectives: The aims of this study were to compare the findings of fluorescence in situ hybridization (FISH) detection of human telomerase RNA gene (hTERC) amplification with that of cytological and human papillomavirus (HPV) DNA tests and explore the possibility to improve the accuracy of the diagnoses of high-grade cervical intraepithelial neoplasia (CIN) and cervical cancer.
Methods: A total of 201 specimens of liquid-based thin-layer cytological examination findings were collected and detected by HPV DNA test and hTERC detected by FISH. All women underwent colposcopy and histological examination of biopsy specimen if needed. The 3 screening methods were compared based on histological examination of colposcopic biopsies.
Results: The amplification of hTERC showed 6.06% in normal or inflammation cases, 10.00% in CIN 1, 66.67% in CIN 2, 72.50% in CIN 3, and 100.00% in carcinoma, with significant difference between the low- (<or=CIN 1 or <or=low-grade squamous intraepithelial lesion) and high-grade (>or=CIN 2 or >or=atypical squamous cells in which high-grade squamous intraepithelial lesion cannot be excluded) cervical lesions (P < 0.001). The hTERC amplification rate was consistent with abnormal rates of cytological and histological diagnoses. The detection of hTERC amplification had a much higher accuracy (87.56%) than the cytological (80.10%) and HPV DNA test (77.61%) findings.
Conclusions: Using FISH to detect the amplification of hTERC had a much higher specificity and accuracy for the diagnoses of high-grade CIN and cervical cancer than cytological and HPV DNA test findings, suggesting that this detection might be a useful and specific screening method in cervical cancer and precancerous lesions.
Similar articles
-
Cytology versus HPV testing for cervical cancer screening in the general population.Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2. Cochrane Database Syst Rev. 2017. PMID: 28796882 Free PMC article.
-
Human telomerase gene and high-risk human papillomavirus infection are related to cervical intraepithelial neoplasia.Asian Pac J Cancer Prev. 2015;16(2):693-7. doi: 10.7314/apjcp.2015.16.2.693. Asian Pac J Cancer Prev. 2015. PMID: 25684510
-
Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.Cochrane Database Syst Rev. 2017 Jan 26;1(1):CD009836. doi: 10.1002/14651858.CD009836.pub2. Cochrane Database Syst Rev. 2017. PMID: 28125861 Free PMC article.
-
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33. Epidemiol Prev. 2012. PMID: 23139163 Italian.
-
Clinical significance of hTERC gene detection in exfoliated cervical epithelial cells for cervical lesions.Int J Gynecol Cancer. 2013 Jun;23(5):785-90. doi: 10.1097/IGC.0b013e31828f39a0. Int J Gynecol Cancer. 2013. PMID: 23669440
Cited by
-
The significant diagnostic value of human telomerase RNA component (hTERC) gene detection in high-grade cervical lesions and invasive cancer.Tumour Biol. 2014 Jul;35(7):6893-900. doi: 10.1007/s13277-014-1915-z. Epub 2014 Apr 16. Tumour Biol. 2014. PMID: 24737583
-
Cytology versus HPV testing for cervical cancer screening in the general population.Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2. Cochrane Database Syst Rev. 2017. PMID: 28796882 Free PMC article.
-
The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study.World J Surg Oncol. 2012 Aug 21;10:168. doi: 10.1186/1477-7819-10-168. World J Surg Oncol. 2012. PMID: 22909227 Free PMC article.
-
3q26 amplification is an effective negative triage test for LSIL: a historical prospective study.PLoS One. 2012;7(7):e39101. doi: 10.1371/journal.pone.0039101. Epub 2012 Jul 6. PLoS One. 2012. PMID: 22792164 Free PMC article.